Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02762981
Title Study to Evaluate CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Corcept Therapeutics

ovarian cancer

peritoneum cancer

fallopian tube cancer

Advanced Solid Tumor

triple-receptor negative breast cancer


Nab-paclitaxel + Relacorilant

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.